在静脉血栓症中对外体的调控和临床应用
Fei Shao1,2, Ruchang He3, Yang Jin4
1School of Clinical Medicine, Jining Medical University, Jining, Shandong, China.
Angiology
|February 14, 2025
概括
外体是参与细胞通信的微小囊泡,在静脉血栓形成和进展中起着关键作用. 研究外体的研究为诊断和治疗这种疾病提供了潜在的机会.
科学领域:
- 细胞生物学 细胞生物学
- 血管生物学 血管生物学
- 生物化学 生物化学
背景情况:
- 外体是哺乳动物细胞释放的细胞外囊泡 (30-150 nm),携带各种生物分子,如蛋白质和微RNA.
- 这些囊泡调解细胞间通信,影响受体细胞的行为和生理过程.
- 静脉血栓症涉及血管内皮损伤,血液动力学变化和血液高凝血能力.
研究的目的:
- 审查外体的生物特征.
- 阐明外体细胞参与静脉血栓形成的机制.
- 探索外体在静脉血栓症诊断和治疗中的临床应用.
主要方法:
- 对外体生物学和功能研究的文献综述.
- 对详细介绍血栓病变发病过程中的外体组作用的研究进行分析.
- 综合关于基于外体的诊断标记和治疗策略的信息.
主要成果:
- 外基因组与静脉血栓形成的各个方面有关.
- 不同的细胞衍生外体会影响血栓形成和分辨率.
- 外体体显示出作为诊断生物标志物和药物输送载体的潜力.
结论:
- 外体是静脉血栓形成的关键调解者.
- 了解外体生物学对于开发新型诊断和治疗方法至关重要.
- 外体有望在治疗静脉血栓的临床应用中发挥作用.
相关概念视频
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
597
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
597
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K


